These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35157269)

  • 1. Preparation of Immune and Synthetic VNAR Libraries as Sources of High-Affinity Binders.
    Gasperin-Bulbarela J; Cabanillas-Bernal O; Dueñas S; Licea-Navarro AF
    Methods Mol Biol; 2022; 2446():71-93. PubMed ID: 35157269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic libraries of shark vNAR domains with different cysteine numbers within the CDR3.
    Cabanillas-Bernal O; Dueñas S; Ayala-Avila M; Rucavado A; Escalante T; Licea-Navarro AF
    PLoS One; 2019; 14(6):e0213394. PubMed ID: 31206542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shark Attack: high affinity binding proteins derived from shark vNAR domains by stepwise in vitro affinity maturation.
    Zielonka S; Weber N; Becker S; Doerner A; Christmann A; Christmann C; Uth C; Fritz J; Schäfer E; Steinmann B; Empting M; Ockelmann P; Lierz M; Kolmar H
    J Biotechnol; 2014 Dec; 191():236-45. PubMed ID: 24862193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring shark VNAR antibody against infectious diseases using phage display technology.
    Lim HT; Kok BH; Leow CY; Leow CH
    Fish Shellfish Immunol; 2023 Sep; 140():108986. PubMed ID: 37541634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selection and Characterization of Anti-idiotypic Shark Antibody Domains.
    Könning D; Zielonka S; Kaempffe A; Jäger S; Kolmar H; Schröter C
    Methods Mol Biol; 2020; 2070():191-209. PubMed ID: 31625097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of Histidine-Enriched Shark IgNAR Variable Domain Antibody Libraries for the Isolation of pH-Sensitive vNAR Fragments.
    Könning D; Hinz S; Grzeschik J; Schröter C; Krah S; Zielonka S; Kolmar H
    Methods Mol Biol; 2018; 1827():109-127. PubMed ID: 30196494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction and next-generation sequencing analysis of a large phage-displayed V
    Feng M; Bian H; Wu X; Fu T; Fu Y; Hong J; Fleming BD; Flajnik MF; Ho M
    Antib Ther; 2019 Jan; 2(1):1-11. PubMed ID: 30627698
    [No Abstract]   [Full Text] [Related]  

  • 8. Generation of Semi-Synthetic Shark IgNAR Single-Domain Antibody Libraries.
    Grzeschik J; Könning D; Hinz SC; Krah S; Schröter C; Empting M; Kolmar H; Zielonka S
    Methods Mol Biol; 2018; 1701():147-167. PubMed ID: 29116504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and characterization of malaria PfHRP2 specific V
    Leow CH; Fischer K; Leow CY; Braet K; Cheng Q; McCarthy J
    Malar J; 2018 Oct; 17(1):383. PubMed ID: 30355309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Semi-synthetic vNAR libraries screened against therapeutic antibodies primarily deliver anti-idiotypic binders.
    Könning D; Rhiel L; Empting M; Grzeschik J; Sellmann C; Schröter C; Zielonka S; Dickgießer S; Pirzer T; Yanakieva D; Becker S; Kolmar H
    Sci Rep; 2017 Aug; 7(1):9676. PubMed ID: 28852148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ancient species offers contemporary therapeutics: an update on shark V
    English H; Hong J; Ho M
    Antib Ther; 2020 Jan; 3(1):1-9. PubMed ID: 32118195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific Targeting of Lymphoma Cells Using Semisynthetic Anti-Idiotype Shark Antibodies.
    Macarrón Palacios A; Grzeschik J; Deweid L; Krah S; Zielonka S; Rösner T; Peipp M; Valerius T; Kolmar H
    Front Immunol; 2020; 11():560244. PubMed ID: 33324393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction of Semisynthetic Shark vNAR Yeast Surface Display Antibody Libraries.
    Kolmar H; Grzeschik J; Könning D; Krah S; Zielonka S
    Methods Mol Biol; 2023; 2702():227-243. PubMed ID: 37679622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shark VNAR phage display libraries: An alternative source for therapeutic and diagnostic recombinant antibody fragments.
    Manoutcharian K; Gevorkian G
    Fish Shellfish Immunol; 2023 Jul; 138():108808. PubMed ID: 37169114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unleashing the power of shark variable single domains (VNARs): broadly neutralizing tools for combating SARS-CoV-2.
    Cabanillas-Bernal O; Valdovinos-Navarro BJ; Cervantes-Luevano KE; Sanchez-Campos N; Licea-Navarro AF
    Front Immunol; 2023; 14():1257042. PubMed ID: 37753081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Vitro Maturation of a Humanized Shark VNAR Domain to Improve Its Biophysical Properties.
    Steven J; Ubah OC; Buschhaus M; Kovaleva M; Ferguson L; Porter AJ; Barelle CJ
    Methods Mol Biol; 2020; 2070():115-142. PubMed ID: 31625093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Anti-TNFα VNAR Single Domain Antibodies from Whitespotted Bambooshark (
    Zhao L; Chen M; Wang X; Kang S; Xue W; Li Z
    Mar Drugs; 2022 Apr; 20(5):. PubMed ID: 35621957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation of highly selective IgNAR variable single-domains against a human therapeutic Fc scaffold and their application as tailor-made bioprocessing reagents.
    Buschhaus MJ; Becker S; Porter AJ; Barelle CJ
    Protein Eng Des Sel; 2019 Dec; 32(9):385-399. PubMed ID: 32119084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic Potential of Shark Anti-ICOSL VNAR Domains is Exemplified in a Murine Model of Autoimmune Non-Infectious Uveitis.
    Kovaleva M; Johnson K; Steven J; Barelle CJ; Porter A
    Front Immunol; 2017; 8():1121. PubMed ID: 28993766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of VNAR Libraries from Immunized Sharks and Selection of Target-Specific Clones.
    Dooley H
    Methods Mol Biol; 2022; 2421():57-72. PubMed ID: 34870811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.